Skip to content

FP7

CAREMORE

Cancer Responsiveness Monitoring based on Resistance mutations in CTCs

Programme
Seventh Framework Programme
Started
Ends
Duration
36 months
Total cost
EUR 7,224,029
EU contribution
EUR 5,127,632
Participants
5 from 3 countries
Topic
FP7_HEALTH.2013.0-1
Grant agreement
601760

Coordinated by Navinci Diagnostics AB (SESweden).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium
OrganisationCountryRoleEU contributionRecognised by
Navinci Diagnostics ABSESwedenCoordinatorEUR 843,403PIC (1.00)
Cytotrack ApsDKDenmarkParticipantEUR 1,926,596PIC (1.00)
Erasmus Universitair Medisch Centrum RotterdamNLNetherlandsParticipantEUR 1,473,853PIC (1.00)
Philips Electronics Nederland BVNLNetherlandsParticipantEUR 737,980PIC (1.00)
Stockholms UniversitetSESwedenParticipantEUR 145,800known name (0.95)

Changes of the consortium

First seen on with 5 participants from 3 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.